Welcome to the Nexus of Ethics, Psychology, Morality, Philosophy and Health Care

Welcome to the nexus of ethics, psychology, morality, technology, health care, and philosophy
Showing posts with label Elderly. Show all posts
Showing posts with label Elderly. Show all posts

Tuesday, October 10, 2017

How AI & robotics are transforming social care, retail and the logistics industry

Benedict Dellot and Fabian Wallace-Stephens
RSA.org
Originally published September 18, 2017

Here is an excerpt:

The CHIRON project

CHIRON is a two year project funded by Innovate UK. It strives to design care robotics for the future with a focus on dignity, independence and choice. CHIRON is a set of intelligent modular robotic systems, located in multiple positions around the home. Among its intended uses are to help people with personal hygiene tasks in the morning, get ready for the day, and support them in preparing meals in the kitchen. CHIRON’s various components can be mixed and matched to enable the customer to undertake a wide range of domestic and self-care tasks independently, or to enable a care worker to assist an increased number of customers.

The vision for CHIRON is to move from an ‘end of life’ institutional model, widely regarded as unsustainable and not fit for purpose, to a more dynamic and flexible market that offers people greater choice in the care sector when they require it.

The CHIRON project is being managed by a consortium led by Designability. The key technology partners are Bristol Robotics Laboratory and Shadow Robot Company, who have considerable expertise in conducting pioneering research and development in robotics. Award winning social enterprise care provider, Three Sisters Care will bring user-centred design to the core of the project. Smart Homes & Buildings Association will work to introduce the range of devices that will create CHIRON and make it a valuable presence in people’s homes.

The article is here.

Monday, April 13, 2015

Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia

Maust DT, Kim H, Seyfried LS, et al.
Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia: Number Needed to Harm.
JAMA Psychiatry. Published online March 18, 2015.
doi:10.1001/jamapsychiatry.2014.3018.


Importance

Antipsychotic medications are associated with increased mortality in older adults with dementia, yet their absolute effect on risk relative to no treatment or an alternative psychotropic is unclear.

Objective

To determine the absolute mortality risk increase and number needed to harm (NNH) (ie, number of patients who receive treatment that would be associated with 1 death) of antipsychotic, valproic acid and its derivatives, and antidepressant use in patients with dementia relative to either no treatment or antidepressant treatment.

(cut)

Conclusions and Relevance

The absolute effect of antipsychotics on mortality in elderly patients with dementia may be higher than previously reported and increases with dose.

The research article is here.